Editor’s note: “Our COVID-19 Fighters” is an occasional series highlighting the ways the CU Anschutz Medical Campus community is helping patients and the wider community in the fight against the pandemic. We welcome your story ideas; please share them here.
Using a high-quality antibody test produced within their own walls, researchers at the Barbara Davis Center for Diabetes (BDC) aim to answer questions about COVID-19’s effect on their patients – including whether SARS-CoV-2 can trigger one of the nation’s top chronic diseases.